SRPT Sarepta Therapeutics Potential Buyout Soon
If you haven`t bought SRPT here:
Then you need to know that there is a Massive catalyst coming!
Sarepta Therapeutics is going to announce Duchenne muscular dystrophy Phase 3 data for its SRP-9001-301 - (EMBARK) by mid November.
This week institutions bought calls worth more than 10Mil that SRPT Sarepta Therapeutics will trade above $135 by November 17.
Some even bought the $210 strike price!
They also have a big partnership with the giant Roche Holding AG (RHHBY).
I think SRPT Sarepta Therapeutics is well positioned for a potential takeover soon!
Looking forward to read your opinion about it.
Then you need to know that there is a Massive catalyst coming!
Sarepta Therapeutics is going to announce Duchenne muscular dystrophy Phase 3 data for its SRP-9001-301 - (EMBARK) by mid November.
This week institutions bought calls worth more than 10Mil that SRPT Sarepta Therapeutics will trade above $135 by November 17.
Some even bought the $210 strike price!
They also have a big partnership with the giant Roche Holding AG (RHHBY).
I think SRPT Sarepta Therapeutics is well positioned for a potential takeover soon!
Looking forward to read your opinion about it.
Private Signals patreon.com/PremiumOptionsSignals
BUYSELL indicators tradingindicators.store/
TRADING COURSE bit.ly/tradex
RESULTS bit.ly/topgx
1%/DAY: bit.ly/3F56VTW
BYBIT partner.bybit.com/b/37880
BUYSELL indicators tradingindicators.store/
TRADING COURSE bit.ly/tradex
RESULTS bit.ly/topgx
1%/DAY: bit.ly/3F56VTW
BYBIT partner.bybit.com/b/37880
פרסומים קשורים
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.